Pricing Log in Create free account

Imunon, Inc. (IMNN) vs Heatwurx Inc. (PCSA)

Imunon, Inc. and Heatwurx Inc. are both Biotechnology companies. Imunon, Inc. and Heatwurx Inc. are of similar size ($5.1M and $5.1M). Imunon, Inc. grew revenue faster over the last twelve months: 0.00% against −34.5%. Across the 12 metrics below, Heatwurx Inc. leads on 7 and Imunon, Inc. on 5.

Valuation

Metric IMNN PCSA Biotechnology median
P/E n/m n/m 10.60
P/S 8.90 39.69 9.40
P/B 2.30 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 6.23 49.49 9.02
Earnings yield (450.59%) (299.98%) (32.88%)
Free cash flow yield (341.72%) (252.81%) (23.13%)

Profitability

Metric IMNN PCSA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (641.02%) (464.19%) (51.96%)
Return on assets (123.93%) (262.17%) (46.06%)
Return on invested capital (324.37%) 0.00% 0.00%

Growth

Metric IMNN PCSA Biotechnology median
Revenue growth (TTM) 0.00% (34.50%) 6.76%
EPS growth (last fiscal year) 59.68% 89.29% 29.88%
Revenue growth, 5-year CAGR 0.00% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMNN PCSA Biotechnology median
Debt to equity 1.32 0.00 0.00
Current ratio 1.82 0.87 4.97
Net debt to EBITDA 0.63 0.40 1.01

Dividend

Metric IMNN PCSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMNN PCSA Biotechnology median
Market cap 5.05m 5.14m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack